-
-
-
-
-
-
-
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
-
-
-
-
-
-
-
ARS Pharmaceuticals Announces Conference Call and Webcast for its Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on ARS Pharmaceuticals Inc (SPRY), PT $28
-
-
-
-
-
-
-
ARS Pharmaceuticals Provides Business Highlights and Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
-
-
1,217,542 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

